These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 19896588

  • 1. Can we do better in developing new drugs for Alzheimer's disease?
    Gauthier S, Scheltens P.
    Alzheimers Dement; 2009 Nov; 5(6):489-91. PubMed ID: 19896588
    [Abstract] [Full Text] [Related]

  • 2. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R.
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [Abstract] [Full Text] [Related]

  • 3. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M, Ichimiya Y, Nozawa E, Utumi Y, Sugiyama H, Murayama N, Iseki E, Arai H.
    Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
    [Abstract] [Full Text] [Related]

  • 4. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
    Ihl R.
    MMW Fortschr Med; 2002 May 06; Suppl 2():24-6, 28-9. PubMed ID: 12070846
    [Abstract] [Full Text] [Related]

  • 5. Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.
    Choi SH, Kim SY, Na HR, Kim BK, Yang DW, Kwon JC, Park MY.
    Dement Geriatr Cogn Disord; 2008 May 06; 25(5):445-50. PubMed ID: 18401173
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan.
    Fuh JL, Wang SJ.
    Int J Geriatr Psychiatry; 2008 Jan 06; 23(1):73-8. PubMed ID: 17520661
    [Abstract] [Full Text] [Related]

  • 7. Realistic expectations for treatment success in Alzheimer's disease.
    Geldmacher DS, Frolich L, Doody RS, Erkinjuntti T, Vellas B, Jones RW, Banerjee S, Lin P, Sano M.
    J Nutr Health Aging; 2006 Jan 06; 10(5):417-29. PubMed ID: 17066215
    [Abstract] [Full Text] [Related]

  • 8. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
    Cortes F, Portet F, Touchon J, Vellas B.
    J Nutr Health Aging; 2007 Jan 06; 11(4):330-7. PubMed ID: 17653493
    [Abstract] [Full Text] [Related]

  • 9. [Anti-dementia drugs for dementia syndromes--just unkept promises?].
    Ihl R.
    MMW Fortschr Med; 2006 May 15; Spec no. 2():24-6. PubMed ID: 20104710
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS.
    Alzheimers Dement; 2009 Mar 15; 5(2):133-6. PubMed ID: 19328443
    [Abstract] [Full Text] [Related]

  • 12. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R, Bergman H, Touchon J, Gambina G, He Y, Nagel J, Lane R.
    Curr Med Res Opin; 2006 Mar 15; 22(3):483-94. PubMed ID: 16574032
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?
    Sevilla C, Jiménez Caballero PE, Alfonso V, González-Adalid M.
    Dement Geriatr Cogn Disord; 2009 Mar 15; 28(3):196-205. PubMed ID: 19738386
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V, Haglund A, Kowalski J, Langworth S, Winblad B.
    Dement Geriatr Cogn Disord; 2008 Mar 15; 26(5):458-66. PubMed ID: 18984956
    [Abstract] [Full Text] [Related]

  • 20. [Tacrine].
    Dávila C, Viteri C, de Castro P.
    Rev Med Univ Navarra; 1997 Mar 15; 41(1):58-64. PubMed ID: 9527715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.